JAKARTA (Reuters) – Indonesia has approved Merck & Co Inc’s COVID-19 antiviral pill molnupiravir for emergency use, the country’s food and drug agency said in a statement.
A batch of 400,000 pills had arrived in Indonesia, health minister Budi Gunadi Sadikin said this week. The pill was jointly developed by U.S.-based Merck and Ridgeback Biotherapeutics.
(Reporting by Stanley Widianto; Editing by Ed Davies)
Oregon State and Washington State face player exodus amid realignment
Star driver Josef Newgarden fights back tears, accepts blame for breaking rules in IndyCar scandal
James, Lakers facing elimination Saturday. Magic, Pelicans and Heat seek home wins
Marta says this will be her final year with Brazil’s women’s national team
European soccer leagues insist they have no plans for games in the US. A lawsuit could change that
South Dakota governor, a potential Trump running mate, writes in new book about killing her dog
140,000 people did their taxes with the free IRS direct file pilot. But program’s future is unclear
Commerce Department announces new restrictions on U.S. firearms exports
New leaders take on Haiti’s chaos as those living in fear demand swift solutions to gang violence
Private security firm says missile fire seen off the Yemen coast in the Red Sea near crucial strait
South Dakota governor, a potential Trump running mate, writes in new book about killing her dog
140,000 people did their taxes with the free IRS direct file pilot. But program’s future is unclear
Commerce Department announces new restrictions on U.S. firearms exports
Chicago appeals court rejects R. Kelly ‘s challenge of 20-year sentence
